Here is Why Growth Investors Should Buy Merit Medical (MMSI) Now

21.02.25 18:45 Uhr

Werte in diesem Artikel
Aktien

16,60 EUR 2,60 EUR 18,57%

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.Merit Medical (MMSI) is one such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank.Studies have shown that stocks with the best growth features consistently outperform the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better.Here are three of the most important factors that make the stock of this maker of disposable medical devices a great growth pick right now.Earnings GrowthEarnings growth is arguably the most important factor, as stocks exhibiting exceptionally surging profit levels tend to attract the attention of most investors. And for growth investors, double-digit earnings growth is definitely preferable, and often an indication of strong prospects (and stock price gains) for the company under consideration.While the historical EPS growth rate for Merit Medical is 21.5%, investors should actually focus on the projected growth. The company's EPS is expected to grow 11.2% this year, crushing the industry average, which calls for EPS growth of 6.6%.Cash Flow GrowthCash is the lifeblood of any business, but higher-than-average cash flow growth is more beneficial and important for growth-oriented companies than for mature companies. That's because, high cash accumulation enables these companies to undertake new projects without raising expensive outside funds.Right now, year-over-year cash flow growth for Merit Medical is 12.2%, which is higher than many of its peers. In fact, the rate compares to the industry average of -0.2%.While investors should actually consider the current cash flow growth, it's worth taking a look at the historical rate too for putting the current reading into proper perspective. The company's annualized cash flow growth rate has been 11.5% over the past 3-5 years versus the industry average of 2.1%.Promising Earnings Estimate RevisionsBeyond the metrics outlined above, investors should consider the trend in earnings estimate revisions. A positive trend is a plus here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.The current-year earnings estimates for Merit Medical have been revising upward. The Zacks Consensus Estimate for the current year has surged 0.5% over the past month.Bottom LineMerit Medical has not only earned a Growth Score of B based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #2 because of the positive earnings estimate revisions.You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.This combination indicates that Merit Medical is a potential outperformer and a solid choice for growth investors.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.3% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merit Medical Systems, Inc. (MMSI): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Here

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Here

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu NOW Inc When Issued

Wer­bung

Analysen zu NOW Inc When Issued

DatumRatingAnalyst
05.08.2019NOW Market PerformCowen and Company, LLC
03.08.2018NOW BuyStifel, Nicolaus & Co., Inc.
03.08.2018NOW Market PerformCowen and Company, LLC
03.05.2018NOW Market PerformCowen and Company, LLC
15.02.2018NOW BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
03.08.2018NOW BuyStifel, Nicolaus & Co., Inc.
15.02.2018NOW BuyStifel, Nicolaus & Co., Inc.
16.01.2018NOW BuyStifel, Nicolaus & Co., Inc.
06.06.2017NOW BuyStifel, Nicolaus & Co., Inc.
04.05.2017NOW BuySeaport Global Securities
DatumRatingAnalyst
05.08.2019NOW Market PerformCowen and Company, LLC
03.08.2018NOW Market PerformCowen and Company, LLC
03.05.2018NOW Market PerformCowen and Company, LLC
15.02.2018NOW Market PerformCowen and Company, LLC
02.11.2017NOW Market PerformCowen and Company, LLC
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für NOW Inc When Issued nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"